The FDA has lifted the partial clinical hold it placed on trials of Aduro Biotech’s CRS-207 cancer vaccine last month.

Let’s be honest, 2016 was a mess of year, and one that many of us will be happy to see the back of. It saw the loss of a series of beloved actors, actresses…

A law firm is suing Clovis Oncology over statements about the safety and efficacy of its now-scrapped lung cancer candidate rociletinib.

Spectrum has said in a SEC filing that the U.S. regulator has rejected its application for Qapzola (apaziquone) for bladder cancer.

Erytech has withdrawn an application for approval of its tumor starvation drug in Europe after the regulator demanded more data.

The FDA has rejected the marketing application for Dynavax’s hepatitis B vaccine, prompting the company to start looking for a partner.

The little-known small cap Corbus Pharmaceuticals, last year touted as a rival to Vertex, has published positive top-line results from its experimental med…

A combination of lower corporate taxes, a sense that deregulation for meds is coming and pricing issues will be dropped, bumped-up stocks and an influx of…

Regulatory